Abstract:Abstract Cordycepin exhibits anticancer potentials against various types of cancer cells. However, the multitudes of associated aspects of its anticancer properties against T- cell Lymphoma remains obscure. Based on in vitro studies, we reported that cordycepin exhibits an antineoplastic effect, against Dalton’s Lymphoma (DL) cells. This study illustrates antineoplastic effects and associated mechanisms of cordycepin against tumor cells withdrawn from murine T-cells Lymphoma, designated as Dalton’s Lymphoma. Our study reveals that cordycepin demonstrates tumoricidal activities against tumor cells via activating apoptosis and necrosis, including the surplus level of Reactive oxygen species production, declined mitochondrial membrane potentials, altered cell survival, and chromatin fragmentation. Moreover, this study also reported cordycepin-induced cell cycle arrest in tumor cells which further leads to apoptosis of tumor cells. This investigation elucidates the implication of antitumor actions of cordycepin against T- Cell Lymphoma accompanied by mitochondrial-dependent apoptotic pathway and therefore, have great medicinal significance.

Cordycepin, an adenosine analog Induces Apoptosis, ROS Generation, and Suppresses Mitochondrial potentials. Exhibits activities against Dalton’s Lymphoma.